Attention abnormalities in chronic hepatitis c (CHC) patients during peg-interferon alpha and ribavirin (peg-IFNalpha/RBV) therapy may persist after treatment discontinuation
Pawelczyk, T., Strzelecki, D., Pawelczyk, A., Rabe-Jablonska, J.Volume:
22
Language:
english
Journal:
European Psychiatry
DOI:
10.1016/j.eurpsy.2007.01.1030
Date:
March, 2007
File:
PDF, 56 KB
english, 2007